Sign In
Buy ACHV
$4.92
-0.110 (-2.19%)
At Close: Jun 03, 2026
Achieve Life Sciences, Inc. (ACHV) Q3 2022 Earnings Call Transcript
08:14pm, Monday, 14'th Nov 2022
Achieve Life Sciences, Inc. (NASDAQ:ACHV ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Nicole Jones - Investor Relations-CG Capital John Bencich - Chief Executiv
Achieve Life Sciences, Inc. (ACHV) CEO John Bencich on Q2 2022 Results - Earnings Call Transcript
11:06pm, Thursday, 11'th Aug 2022
Achieve Life Sciences, Inc. (NASDAQ:ACHV ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Cindy Jacobs - President, Chief Medical Officer & Director Jerry Wan - Princ
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 11, 2022
08:00am, Thursday, 28'th Jul 2022
SEATTLE and VANCOUVER, British Columbia, July 28, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development
Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference
08:00am, Friday, 13'th May 2022
SEATTLE and VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and co
Achieve Life Sciences, Inc. (ACHV) CEO John Bencich on Q1 2022 Results - Earnings Call Transcript
08:08pm, Thursday, 12'th May 2022
Achieve Life Sciences, Inc. (NASDAQ:ACHV ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants John Bencich - CEO & Director Cindy Jacobs - President, Chief Medical Officer &
Achieve Life Sciences Aces Pivotal Cytisinicline Study In Smoking Cessation
09:47am, Wednesday, 27'th Apr 2022
Achieve Life Sciences Inc (NASDAQ: ACHV) has announced positive topline results from the Phase 3 ORCA-2 trial of 3mg cytisinicline for 6-weeks or 12-weeks compared to a placebo in 810 adult smokers
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 12, 2022
08:00am, Thursday, 21'st Apr 2022
SEATTLE and VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and
Achieve Life Sciences: Initiating Buy, Potential Multi-Billion-Dollar Smoking Cessation Drug
01:38pm, Monday, 04'th Apr 2022
We are initiating ACHV with a buy rating and a target price of USD 70.
Achieve Life Sciences, Inc. (ACHV) CEO John Bencich on Q4 2021 Results - Earnings Call Transcript
11:04pm, Thursday, 10'th Mar 2022 Seeking AlphaAchieve Life Sciences, Inc. (ACHV) CEO John Bencich on Q4 2021 Results - Earnings Call Transcript
06:04pm, Thursday, 10'th Mar 2022
Achieve Life Sciences, Inc. (ACHV) CEO John Bencich on Q4 2021 Results - Earnings Call Transcript
Achieve Life Sciences GAAP EPS of -$0.76 misses by $0.07
02:29pm, Thursday, 10'th Mar 2022 Seeking Alpha
Achieve Life Sciences press release (ACHV): Q4 GAAP EPS of -$0.76 misses by $0.07.As of December 31, 2021, the company’s cash, cash equivalents, and restricted cash was $43.1 million.
Achieve Life Sciences Q4 2021 Earnings Preview (NASDAQ:ACHV)
10:35pm, Wednesday, 09'th Mar 2022 Seeking Alpha
Achieve Life Sciences (NASDAQ:ACHV) is scheduled to announce Q4 earnings results on Thursday, March 10th, after market close.The consensus EPS Estimate is -$0.70 (+36.9% Y/Y) and…
Achieve Life Sciences Announces Participation in March Investor Conferences
08:00am, Tuesday, 08'th Mar 2022
SEATTLE, Wash. and VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global developme
Achieve Life Sciences Announces Participation in February Investor Conferences
08:00am, Wednesday, 02'nd Feb 2022
SEATTLE and VANCOUVER, British Columbia, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and c
Achieve Life commences Phase 3 trial of cytisinicline for smoking cessation
01:26pm, Tuesday, 25'th Jan 2022 Seeking Alpha
Achieve Life Sciences (ACHV) has initiated screening of ORCA-3, the confirmatory Phase 3 trial required for registrational approval of cytisinicline in U.S. ORCA-3 will evaluate
